PainReform Statistics
Total Valuation
PainReform has a market cap or net worth of $3.29 million. The enterprise value is -$922,972.
Important Dates
The next estimated earnings date is Friday, May 23, 2025, after market close.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PainReform has 1.71 million shares outstanding. The number of shares has increased by 206.42% in one year.
| Current Share Class | 1.71M |
| Shares Outstanding | 1.71M |
| Shares Change (YoY) | +206.42% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 5.18% |
| Float | 1.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.81 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -321.92% and return on invested capital (ROIC) is -199.49%.
| Return on Equity (ROE) | -321.92% |
| Return on Assets (ROA) | -126.89% |
| Return on Invested Capital (ROIC) | -199.49% |
| Return on Capital Employed (ROCE) | -704.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.43M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PainReform has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.69% in the last 52 weeks. The beta is 0.69, so PainReform's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -89.69% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 3.57 |
| Relative Strength Index (RSI) | 37.34 |
| Average Volume (20 Days) | 377,857 |
Short Selling Information
The latest short interest is 104,738, so 6.14% of the outstanding shares have been sold short.
| Short Interest | 104,738 |
| Short Previous Month | 316,117 |
| Short % of Shares Out | 6.14% |
| Short % of Float | 6.86% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.67M |
| Pretax Income | -12.53M |
| Net Income | -14.59M |
| EBITDA | -14.66M |
| EBIT | -14.67M |
| Earnings Per Share (EPS) | -$32.16 |
Full Income StatementBalance Sheet
The company has $4.26 million in cash and $45,000 in debt, giving a net cash position of $4.22 million or $2.47 per share.
| Cash & Cash Equivalents | 4.26M |
| Total Debt | 45,000 |
| Net Cash | 4.22M |
| Net Cash Per Share | $2.47 |
| Equity (Book Value) | 1.82M |
| Book Value Per Share | 1.24 |
| Working Capital | 1.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.62 million and capital expenditures -$13,000, giving a free cash flow of -$12.63 million.
| Operating Cash Flow | -12.62M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -12.63M |
| FCF Per Share | -$7.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |